Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114852) titled 'Development and Preliminary Application of a Family Adaptive Intervention Protocol Based on the FAAR Model for Breast Cancer-Related Lymphedema' on Dec. 18, 2025.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Jiangsu Cancer Hospital
Condition:
Breast cancer-related lymphedema
Intervention:
Control group:Routine health education
Intervention group:Family adaptive intervention program
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Control group:18;Intervention group:18;BCRL Patient Family Interview Group:2...